SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IVAX Insider Trading
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: flickerful who wrote (239)12/5/1997 10:26:00 PM
From: 5,17,37,5,101,...  Read Replies (2) of 756
 
Here are a few dates for the record:

4-1-97 Ivax will be seeking approval of Paxene in other countries "soon" per press release.

7-23-97 FDA panel accepts BM-S paclitaxel for consideration in use against K-S.

8-4-97 FDA accepts BM-S paclitaxel "efficacy supplement" (orphan drug status) for use against K-S [pretty quick acceptance, really]

9-19-97 FDA panel accepts Ivax's Paxene for futher consideration in use against K-S.

12-5-97 We are still waiting to hear of any kind of Paxene approval anywhere.

Jackson
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News